Letter by Kruszelnicka et al regarding article, "evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs".
Department of Coronary Artery Disease and Heart Failure, John Paul II Hospital, Cracow, Poland.
Olga
O
Kruszelnicka
Department of Nephrology, University Hospital, Cracow, Poland.
Ewa
E
Wieczorek-Surdacka
Second Department of Cardiology, Jagiellonian University, Cracow, Poland.
Andrzej
A
Surdacki
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001120:Arginine / Q000031:analogs & derivatives*; D002318:Cardiovascular Diseases / Q000097:blood*; D051546:Cyclooxygenase 2 / Q000172:deficiency*; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male
D000893:Anti-Inflammatory Agents; D052246:Cyclooxygenase 2 Inhibitors; D001120:Arginine; D051546:Cyclooxygenase 2